Curaleaf says it does not comment on market speculation amid reports it may be interested in Cronos

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

Curaleaf Holdings Inc. said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company...

Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CA:CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

... Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cronos Group stock rises in premarket as it confirms merger talksCronos Group Inc. stock is up nearly 6% in premarket trades on Friday after the Canadian cannabis company said it’s reviewing unsolicited indications of...
Source: MarketWatch - 🏆 3. / 97 Read more »

Bed Bath & Beyond investors have spent $200 million trading 'worthless' shares — will this holding company help them?Bed Bath & Beyond investors have spent $200 million trading ‘worthless’ shares — will this holding company help them?
Source: MarketWatch - 🏆 3. / 97 Read more »